Autonomix Medical Inc (NASDAQ:AMIX) blasted higher Monday after the company entered into an agreement with RF Innovations to license intellectual property for its Apex 6 Radiofrequency Generator.

What To Know: Autonomix said the transaction, for 250,000 shares of common stock, grants Autonomix a perpetual non-exclusive worldwide and royalty-free license of the Apex 6 Generator intellectual property.

The Apex 6 Radiofrequency Generator is an FDA-cleared ablation technology designed to lesion neural tissue for pain management in the peripheral nervous system.

The transaction is expected to close before the end of July, and Autonomix said it plans to utilize the technology in its strategic therapeutic areas to drive value across its pipeline.

What Else: Autonomix shares soared on heavy trading volume following the announcement Monday. According to data from Benzinga Pro, 153.415 million shares were traded in the session, compared to the stock's 100-day average of less than 459,000 shares.

Autonomix Medical shares were halted multiple times for volatility and ended Monday's session 123.3% higher at $1.38.

How To Buy AMIX Stock

Besides going to a brokerage platform to purchase a share — or fractional share — of stock, you can also gain access to shares either by buying an exchange-traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument.

For example, for Autonomix Medical, it's in the Health Care sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.

AMIX Price Action: According to Benzinga Pro, Autonomix Medical shares are down 9.42% after-hours at $1.25 at the time of publication Monday.

Read Also:

• What's Going On With Meta Platforms Stock?

Image: Shutterstock